World Parkinson Congress Blog

Dyskinesia and Parkinson’s Disease

Dyskinesia and Parkinson’s Disease

by Tyler Okelberry, MD and Rajesh Pahwa, MD

Clinical ScienceTyler Okelberry, MD and Rajesh Pahwa, MDApril 5, 2024Parkinson's, Dyskinesia, WPC2023, Nine, LevodopaComment

Beyond Color: The Hidden Impact of Neuromelanin In The Brain

Beyond Color: The Hidden Impact of Neuromelanin In The Brain

by Núria Peñuelas, PhD

Basic ScienceNúria Peñuelas, PhDMarch 25, 2024Neuromelanin, Neuronal vulnerability, Preclinical models, Aging, Parkinson's, WPC2023, NineComment

Could Subgrouping Parkinson’s Disease Using Cellular Phenotyping Enable Success at Clinical Trials?

Could Subgrouping Parkinson’s Disease Using Cellular Phenotyping Enable Success at Clinical Trials?

by Toby Burgess PhD Student

Basic ScienceToby Burgess PhD StudentMarch 13, 2024Parkinson, Clinical Trials, Brain, NineComment

Parkinson’s Beats – The Exercise That Makes You Come Back For More

Parkinson’s Beats – The Exercise That Makes You Come Back For More

by Jo Holland and Julie Jones

Comprehensive LivingJo Holland and Julie JonesFebruary 28, 2024Parkinson, Excercise, exercise motivation, Nine Comments

Pre-Clinical Models of Levodopa - Induced Dyskinesia

Pre-Clinical Models of Levodopa - Induced Dyskinesia

by Philippe Huot, MD, PhD

Clinical SciencePhilippe Huot, MD, PhDFebruary 14, 2024Parkinson's, Levodopa, dysphagia, Nine Comment

Unveiling the Impact of Apathy on Parkinson's Disease: A Gendered Perspective

Unveiling the Impact of Apathy on Parkinson's Disease: A Gendered Perspective

by Ana Jimena Hernández-Medrano, MD, MSc-candidate

Comprehensive LivingAna Jimena Hernández-Medrano, MDJanuary 31, 2024Parkinson's Disease, Apathy, Gender equity, Quality of Life, NineComment

Impact of Alpha-Synuclein Pathology on the Blood-Brain Barrier

Impact of Alpha-Synuclein Pathology on the Blood-Brain Barrier

by Kristina Lau, PhD student

Basic ScienceKristina Lau, PhD studentJanuary 17, 2024Brain capillaries, Endothelial activation, Alpha-synuclein pathology, Transporter proteins, Vessel density, Parkinson's, NineComment

Zoom Into Different Flavors of Dopaminergic Neurons

Zoom Into Different Flavors of Dopaminergic Neurons

by Kawai Lee, PhD student

Basic ScienceKawai LeeJanuary 3, 2024Parkinson's, Neurons, Nine Comment

The Role of Physical Therapy in the Management of Parkinson Disease

The Role of Physical Therapy in the Management of Parkinson Disease

by Katherine Marita, DPT

Clinical Science, Comprehensive LivingKatherine Marita, DPTDecember 6, 2023Physical therapy, Physical therapist, Physiotherapist, Rehabilitation, Exercise, Mobility, Movement, Walking, eightComment

Proactive Integrated Management and Empowerment in Parkinson’s

Proactive Integrated Management and Empowerment in Parkinson’s

by Dr Katie Lloyd MBChB MRCP (UK) BSc

Clinical ScienceDr Katie Lloyd MBChB MRCP BScNovember 20, 2023parkinsons, Health Care, Care Models, Clinical Trials, Process evaluation, Eight Comments

Novel Targets for Parkinson`s Disease Research – The Flcn Gene and its Role in Dopaminergic Neurons

Novel Targets for Parkinson`s Disease Research – The Flcn Gene and its Role in Dopaminergic Neurons

by Julia Obergasteiger

Basic ScienceJulia ObergasteigerNovember 8, 2023Eight, Parkinson's, research, GeneticsComment

PD GENEration: Creating the Largest PD Genetics Registry Study in North America

PD GENEration: Creating the Largest PD Genetics Registry Study in North America

by Kamalini Ghosh Galvelis, MS

AdvocacyKamalini Ghosh Galvelis, MSOctober 25, 2023eight, Genetics, Parkinson's Comment

The Lysosomes, a Key Player in the Parkinon’s Disease Pathology

The Lysosomes, a Key Player in the Parkinon’s Disease Pathology

by María Sanchiz Calvo PhD Student

Basic ScienceMaría Sanchiz Calvo, PhD StudentOctober 11, 2023eight, Parkinson's, PathologyComment

A New Treatment for Fluctuating and Dyskinetic L-dopa Complications

A New Treatment for Fluctuating and Dyskinetic L-dopa Complications

by Prof David Devos, MD, PhD

Basic ScienceProf David Devos, MD, PhDSeptember 27, 2023Eight, Parkinson's, Brain Comment

Could Changes in Gut Bacteria Contribute to the Development of Parkinson’s Disease in Those with Genetic Risk?

Could Changes in Gut Bacteria Contribute to the Development of Parkinson’s Disease in Those with Genetic Risk?

by Christin Weissleder, PhD

Basic ScienceChristin Weissleder, PhDSeptember 18, 2023parkinsons, WPC2023, gut, eightComment

A Missing Piece of the Parkinson’s Puzzle: The Critical Role of the Dietitian in the care of People with Parkinson’s Disease

A Missing Piece of the Parkinson’s Puzzle: The Critical Role of the Dietitian in the care of People with Parkinson’s Disease

by Richelle Flanagan

Living with Parkinson'sRichelle FlanaganAugust 30, 2023parkinsons, WPC2023, Diet, Therapies, eightComment

NLX-112: a First-in-Class, Dual-Acting, Non-Dopaminergic, Drug Candidate for Treatment of Parkinson’s Disease

NLX-112: a First-in-Class, Dual-Acting, Non-Dopaminergic, Drug Candidate for Treatment of Parkinson’s Disease

by Adrian Newman-Tancredi, PhD, DSc

Clinical ScienceAdrian Newman-Tancredi, PhD, DScAugust 14, 2023Eight, WPC2023, clinical research, levodopa-induced dyskinesia, serotonin, parkinsonism, 5 HT1A receptor Comments

Better Advice I Have Never Received

Better Advice I Have Never Received

by Rebecca Miller, PhD

Living with Parkinson'sRebecca Miller PhDJuly 31, 2023parkinsons, WPC2023, eight Comment

The Secret Sauce: What Makes WPC The Best Scientific Conference on Parkinson’s in the World?

The Secret Sauce: What Makes WPC The Best Scientific Conference on Parkinson’s in the World?

by Sara Riggare, MSc, PhD

Living with Parkinson'sSara Riggare MSc, PhDJuly 24, 2023parkinsons, WPC2023, eight, World Parkinson Congress Comments

WPC Withdrawal Syndrome

WPC Withdrawal Syndrome

by Richelle Flanagan

Living with Parkinson'sRichelle FlanaganJuly 17, 2023parkinsons, WPC2023, eight Comments